The biggest changes appeared at moments that depend on first impressions: getting hired or finding a new partner
The SURMOUNT-5 trial later confirmed that tirzepatide produced 47% greater weight loss than semaglutide in a head-to-head comparison, solidifying its position as a leading option for weight management
Learn the risks, correct charging voltage, safe charger options, and what to do after a mistake
This can result from reduced caloric intake, metabolic adjustment, or both
The ideal candidate is someone with age-related or genetic facial volume loss as the main concern, adequate donor fat available (lean patients may not have enough), stable weight for at least 6 months, non-smoker or willing to stop for 6 weeks before and after surgery, and realistic expectations about what volume restoration can and cannot achieve
External Links: This blog post may contain links to external websites or resources for additional information